<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03641261</url>
  </required_header>
  <id_info>
    <org_study_id>RC31/16/8765</org_study_id>
    <nct_id>NCT03641261</nct_id>
  </id_info>
  <brief_title>Therapeutic Education Using an Internet Application in Hereditary Ichthyosis</brief_title>
  <acronym>e-ETPichtyose</acronym>
  <official_title>Evaluation of the Feasibility and Effect of Therapeutic Education Sessions Using an Internet Application in Hereditary Ichthyosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Toulouse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Toulouse</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main purpose is to evaluate the feasibility (global use) of a therapeutic patient
      education program using a specific web application in patients with hereditary ichthyosis.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 29, 2018</start_date>
  <completion_date type="Anticipated">February 2021</completion_date>
  <primary_completion_date type="Anticipated">November 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Global use</measure>
    <time_frame>6 months</time_frame>
    <description>percentage of patients who have used the &quot;WebIchtyose&quot; application for at least 8 hours during 6 months</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fractional use in each domain (educational sessions)</measure>
    <time_frame>6 months</time_frame>
    <description>&quot;WebIchtyose&quot; application use time by the patient for group and individual educational sessions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fractional use in each domain (continuous educational follow-up)</measure>
    <time_frame>6 months</time_frame>
    <description>&quot;WebIchtyose&quot; application use time by the patient for the continuous educational follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fractional use in each domain (consultation)</measure>
    <time_frame>6 months</time_frame>
    <description>&quot;WebIchtyose&quot; application use time by the patient for the consultation of the &quot;Frequently Asked Questions&quot; area and of patient information documents made available on the application</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fractional use in each domain (questionnaires)</measure>
    <time_frame>6 months</time_frame>
    <description>&quot;WebIchtyose&quot; application use time by the patient for the filling of the questionnaires</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fractional use in each domain</measure>
    <time_frame>6 months</time_frame>
    <description>&quot;WebIchtyose&quot; application use time by the patient for group and individual educational sessions, the continuous educational follow-up, the consultation of the &quot;Frequently Asked Questions&quot; area and of patient information documents made available on the application</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difficulty of individual application registration</measure>
    <time_frame>Baseline</time_frame>
    <description>Difficulty of registration questionnaire completed for each patient jointly by the patient and the educational team at the end of the face-to-face inclusion visit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difficulties of use in everyday life by the patient</measure>
    <time_frame>6 months</time_frame>
    <description>Questionnaire completed for each patient jointly by the patient at the end of the program</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of exchanges</measure>
    <time_frame>3 months and 5 months</time_frame>
    <description>Number of exchanges necessary between the educational team and the patient to set a date for the conduct of the individual educational sessions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Response time</measure>
    <time_frame>6 months</time_frame>
    <description>Response time of the educational team following a request from the patient as part of the educational follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of relaunches</measure>
    <time_frame>2 months, 4 months and 6 months</time_frame>
    <description>How many times the nurse relaunches the patient to obtain the assessment questionnaires</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of non-received questionnaires</measure>
    <time_frame>2 months, 4 months and 6 months</time_frame>
    <description>Number of non-received questionnaires after relaunch</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of lost to follow-up patients</measure>
    <time_frame>9 months</time_frame>
    <description>Number of lost to follow-up patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient acceptability</measure>
    <time_frame>6 months</time_frame>
    <description>Acceptability questionnaire to be completed by the patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Educational team acceptability</measure>
    <time_frame>6 months</time_frame>
    <description>Acceptability questionnaire to be completed by each member of the educational team</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Attractiveness</measure>
    <time_frame>6 months</time_frame>
    <description>Application attractiveness questionnaire completed by the patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life before and after treatment</measure>
    <time_frame>Inclusion, 6 months and 9 months</time_frame>
    <description>Quality of life questionnaire for hereditary ichthyosis (IQoL-32)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-assessment of cutaneous severity</measure>
    <time_frame>Inclusion and 6 months</time_frame>
    <description>Self-assessment of cutaneous severity according to an analogic visual scale for pain, pruritus, erythema, squama</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Knowledge about disease and treatments</measure>
    <time_frame>Inclusion and 6 months</time_frame>
    <description>Questionnaire of knowledge about disease and treatments</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-care skills</measure>
    <time_frame>Inclusion and 6 months</time_frame>
    <description>Questionnaire of self-care skills</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-esteem</measure>
    <time_frame>Inclusion and 6 months</time_frame>
    <description>Questionnaire about self-esteem: Rosenberg scale. For each item of the questionnaire, the modality answers are : 1 (totally disagree), 2 (quite disagree), 3 (quite agree) and 4 (totally disagree). The total score (/ 40) is calculated by adding the scores obtained for each item.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Coping scale</measure>
    <time_frame>Inclusion and 6 months</time_frame>
    <description>Coping with health injuries and problem (Endler 1998). For each item of the questionnaire, the modality answers are: 1 (not at all), 2 (a little), 3 (moderately), 4 (often) and 5 (a lot).The total score (/ 160) is calculated by adding the scores obtained for each item.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">42</enrollment>
  <condition>Ichthyosis</condition>
  <arm_group>
    <arm_group_label>Therapeutic Patient Education program</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All included patients will follow a Therapeutic Patient Education program dedicated to the hereditary ichthyosis and using a web application, WebIchtyose</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Therapeutic patient education program</intervention_name>
    <description>WebIchtyose is a specific therapeutic patient education program for patients with hereditary Ichthyosis targeting the problems of each patient by means of a personalized follow-up and a constant interaction between the patient and the educational team</description>
    <arm_group_label>Therapeutic Patient Education program</arm_group_label>
    <other_name>WebIchtyose</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient with hereditary ichthyosis, according to the classification established during
             the 2009 consensus conference

          -  Who has given his informed consent form

          -  Who is affiliated to a social security system

        Exclusion Criteria:

          -  Patient who has already participated in a therapeutic patient education program for
             the hereditary ichthyosis

          -  Unable to connect or use a computer tool

          -  Impossibility to be present at the only face-to-face session

          -  Patient who is not available for the collective educational session

          -  Patient with little or no motivation to follow a therapeutic patient education program
             (motivation evaluated by the educational team by phone call before inclusion)

          -  Patient not mastering the French language

          -  Person under legal protection (guardianship, curators or safeguard of justice)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Juliette Mazereeuw-Hautier, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Toulouse</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Juliette Mazereeuw-Hautier, MD</last_name>
    <phone>05 61 77 81 41</phone>
    <phone_ext>+33</phone_ext>
    <email>mazereeuw-hautier.j@chu-toulouse.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Isabelle Dreyfus, PharmD</last_name>
    <phone>05 67 77 81 10</phone>
    <phone_ext>+33</phone_ext>
    <email>dreyfus.i@chu-toulouse.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU Toulouse, Hôpital Larrey</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juliette Mazereeuw-Hautier, MD</last_name>
      <phone>05 67 77 81 41</phone>
      <phone_ext>+33</phone_ext>
      <email>mazereeuw-hautier.j@chu-toulouse.fr</email>
    </contact>
    <contact_backup>
      <last_name>Isabelle Dreyfus, PharmD</last_name>
      <phone>05 67 77 81 10</phone>
      <phone_ext>+33</phone_ext>
      <email>dreyfus.i@chu-toulouse.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Juliette Mazereeuw-Hautier, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>June 4, 2018</study_first_submitted>
  <study_first_submitted_qc>August 17, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 21, 2018</study_first_posted>
  <last_update_submitted>July 11, 2019</last_update_submitted>
  <last_update_submitted_qc>July 11, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hereditary ichthyosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ichthyosis</mesh_term>
    <mesh_term>Ichthyosis, Lamellar</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

